ARCHIVES

Nevins Reverses Position, Claims Potti Manipulated Data For Basis of Clinical Trials

This article is from The Cancer Letter archive.

Vol. 38 No. 07 | February 17, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Plans Study Of Its Authorities. FDA, NIH To Provide $6.75 Million For Grants In Regulatory Science

February 26, 2010

Phase 0 Trials Signal FDA’s New Reliance On Biomarkers For Drug Development.

January 13, 2006

BCDDP “Major Accomplishment” Described By ACS’ Holleb

July 21, 1978

Cancer Center Planning Grants Recompetition Approved By Advisors

June 10, 1994

Dingell To Challenge NCI, NSABP Handling Of Fraud, Delays

April 8, 1994

Senate Passes Biomedical Research Extension; Could Go to President before Congress Recesses

July 26, 1985